Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 132.21

-0.3%

Jan 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: smh who wrote (151)	4/24/1999 10:45:00 PM
From: LLCF	Read Replies (1) of 1834

<Is your thinking the same on vrtx?> Yes, I've done very well being a "scaled buyer" in several stocks after they get approval of their first drug (CORR, CEPH, now VRTX?)... NBIX is different I supposed but just getting silly IMO. Here (NBIX) I believe when this sellers done it will pop just because there won't be anyone else stupid enough to sell at these levels... these are thin stocks. Back to VRTX et al: if you look at the others (like CORR, and CEPH) they had QUITE A TUMBLE after that IMO because of their lack of pipeline... everyone said... O.K what next? Nothing? OOPPSS Of course there is also the perception that the approved products themselves were nothing to write home about... that said the stocks got way oversold and have come back nicely. We'll see how sales go, but it's already clear that these are real products and not some "also ran" like some first products. With VRTX I don't believe the correction will be as deep because 1.) they have such a pipeline 2.) They may be a takeover candidate 3.) they have tons of cash I've started nibbling on VRTX at these levels even though I think the stock could hit $18 or so before it's over. Just my opinion. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next